|
ASAP3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
|
|
|
|
ATP6V0C |
ATPase H+ transporting V0 subunit c |
- ROS and RNS production in phagocytes
- Neutrophil degranulation
- Insulin receptor recycling
- Transferrin endocytosis and recycling
- Amino acids regulate mTORC1
- Ion channel transport
|
|
|
|
CAPN1 |
calpain 1 |
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Neutrophil degranulation
- Formation of the cornified envelope
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
|
- 4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium
- N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-3-fluoro-1-(4-hydroxybenzyl)-2-oxopropyl]-L-leucinamide
- (2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE
|
|
|
CHRM3 |
cholinergic receptor muscarinic 3 |
- Muscarinic acetylcholine receptors
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
|
- Cevimeline
- Tramadol
- Succinylcholine
- Trospium
- Ziprasidone
- Disopyramide
- Amitriptyline
- Ipratropium
- Olanzapine
- Metixene
- Terfenadine
- Clozapine
- Doxylamine
- Trihexyphenidyl
- Oxyphencyclimine
- Procyclidine
- Loxapine
- Carbamoylcholine
- Hyoscyamine
- Cyproheptadine
- Meperidine
- Imipramine
- Methscopolamine bromide
- Chlorpromazine
- Darifenacin
- Haloperidol
- Tridihexethyl
- Anisotropine methylbromide
- Nortriptyline
- Amoxapine
- Cinnarizine
- Atropine
- Thiopental
- Nicardipine
- Paroxetine
- Homatropine methylbromide
- Trimipramine
- Scopolamine
- Benzquinamide
- Propiomazine
- Tropicamide
- Brompheniramine
- Maprotiline
- Methantheline
- Glycopyrronium
- Bethanechol
- Tolterodine
- Oxybutynin
- Promethazine
- Pilocarpine
- Doxepin
- Desipramine
- Ketamine
- Quetiapine
- Mivacurium
- Diphenidol
- Aripiprazole
- Chlorprothixene
- Pancuronium
- Pipecuronium
- Methotrimeprazine
- Tiotropium
- Solifenacin
- Isopropamide
- Acetylcholine
- Arecoline
- Mepenzolate
- ALKS 27
- Pizotifen
- Fesoterodine
- Methacholine
- Hexocyclium
- Aclidinium
- Umeclidinium
- Trimebutine
- Dosulepin
- Etoperidone
- Imidafenacin
- Butylscopolamine
- Homatropine
- Thonzylamine
- Revefenacin
- Propiverine
- Rociverine
- Diphemanil
- Aripiprazole lauroxil
|
|
|
CYTH1 |
cytohesin 1 |
|
|
|
|
CYTH2 |
cytohesin 2 |
|
- Inositol 1,3,4,5-Tetrakisphosphate
- Formic acid
- 1D-myo-inositol 1,4,5-trisphosphate
- S,S-(2-Hydroxyethyl)Thiocysteine
- Brefeldin A
|
|
|
EXOC5 |
exocyst complex component 5 |
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Insulin processing
- VxPx cargo-targeting to cilium
|
|
|
|
EZR |
ezrin |
- Netrin-1 signaling
- Recycling pathway of L1
- Recycling pathway of L1
|
|
|
|
HTR2A |
5-hydroxytryptamine receptor 2A |
- Serotonin receptors
- G alpha (q) signalling events
|
- Ziprasidone
- Methysergide
- Cabergoline
- Zolmitriptan
- Amitriptyline
- Olanzapine
- Clozapine
- Mirtazapine
- Loxapine
- Remoxipride
- Promazine
- Cyproheptadine
- Imipramine
- Chlorpromazine
- Chlorpromazine
- Haloperidol
- Nortriptyline
- Amoxapine
- Lamotrigine
- Fenfluramine
- Lisuride
- Cisapride
- Fluphenazine
- Trazodone
- Thioridazine
- Ergotamine
- Apomorphine
- Paroxetine
- Paroxetine
- Trimipramine
- Risperidone
- Epinastine
- Propiomazine
- Minaprine
- Donepezil
- Flupentixol
- Cyclobenzaprine
- Mesoridazine
- Maprotiline
- Ergoloid mesylate
- Tegaserod
- Doxepin
- Nefazodone
- Desipramine
- Escitalopram
- Pergolide
- Bromocriptine
- Ketamine
- Quetiapine
- Aripiprazole
- Chlorprothixene
- Chlorprothixene
- Clomipramine
- Paliperidone
- Yohimbine
- Methotrimeprazine
- MMDA
- Midomafetamine
- Dimethyltryptamine
- 4-Bromo-2,5-dimethoxyphenethylamine
- Acepromazine
- Molindone
- Pipotiazine
- Thioproperazine
- Thiothixene
- Zuclopenthixol
- Aniracetam
- Fluspirilene
- Flibanserin
- Iloperidone
- HY10275
- APD791
- Pimavanserin
- Epicept NP-1
- BL-1020
- Cariprazine
- Lumateperone
- YKP-1358
- Sertindole
- Mianserin
- Pizotifen
- Asenapine
- Ocaperidone
- Amisulpride
- Dotarizine
- Deramciclane
- Esmirtazapine
- Cinitapride
- Lurasidone
- Serotonin
- Perospirone
- Amperozide
- Butriptyline
- Cannabidiol
- Brexpiprazole
- Dosulepin
- Etoperidone
- Lorpiprazole
- Blonanserin
- Zotepine
- Pipamperone
- Setiptiline
- Dihydroergocornine
- Gilteritinib
- Sarpogrelate
- Eplivanserin
- Ketanserin
- Nelotanserin
- Ritanserin
- Tiapride
- Dihydroergocristine
- 2,5-Dimethoxy-4-ethylthioamphetamine
- N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
- Medical Cannabis
- 5-methoxy-N,N-dimethyltryptamine
- Nabiximols
- Aripiprazole lauroxil
|
|
|
IKBKG |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
- Activation of NF-kappaB in B cells
- Activation of NF-kappaB in B cells
- ER-Phagosome pathway
- NOD1/2 Signaling Pathway
- TICAM1, RIP1-mediated IKK complex recruitment
- RIP-mediated NFkB activation via ZBP1
- Downstream TCR signaling
- FCERI mediated NF-kB activation
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- activated TAK1 mediates p38 MAPK activation
- JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
- SUMOylation of immune response proteins
- Regulation of TNFR1 signaling
- TNFR1-induced NFkappaB signaling pathway
- IKBKB deficiency causes SCID
- IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
- IkBA variant leads to EDA-ID
- CLEC7A (Dectin-1) signaling
- MAP3K8 (TPL2)-dependent MAPK1/3 activation
- Ub-specific processing proteases
- Ovarian tumor domain proteases
- Interleukin-1 signaling
- TRAF6 mediated NF-kB activation
- NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
- IRAK1 recruits IKK complex
- IKK complex recruitment mediated by RIP1
- IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
|
|
- Ectodermal dysplasia associated immunodeficiency (EDA-ID), including the following two diseases: NF-kappa-B essential modulator (NEMO) defect; Inhibitor of kappa-B (I-kappa-B) defect
- Incontinentia pigmenti
- Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID); Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema
|
|
ITSN1 |
intersectin 1 |
- NRAGE signals death through JNK
- Rho GTPase cycle
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- G alpha (12/13) signalling events
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
|
|
|
|
MEOX2 |
mesenchyme homeobox 2 |
|
|
|
|
MT2A |
metallothionein 2A |
- Metallothioneins bind metals
- Metallothioneins bind metals
- Interferon gamma signaling
|
- Zinc
- Silver
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
PALS1 |
protein associated with LIN7 1, MAGUK family member |
- Tight junction interactions
|
|
|
|
PIP5K1A |
phosphatidylinositol-4-phosphate 5-kinase type 1 alpha |
- Synthesis of PIPs at the plasma membrane
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
|
|
|
PIP5K1C |
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma |
- Synthesis of PIPs at the plasma membrane
- SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Clathrin-mediated endocytosis
|
|
- Lethal congenital contractural syndrome (LCCS)
|
|
PLD1 |
phospholipase D1 |
- Synthesis of PG
- Synthesis of PA
- Role of phospholipids in phagocytosis
- Neutrophil degranulation
|
- Choline
- LAX-101
- Choline salicylate
|
|
|
RAB11A |
RAB11A, member RAS oncogene family |
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Vasopressin regulates renal water homeostasis via Aquaporins
- Anchoring of the basal body to the plasma membrane
- VxPx cargo-targeting to cilium
- TBC/RABGAPs
- RAB geranylgeranylation
|
- 5'-Guanosine-Diphosphate-Monothiophosphate
- Guanosine-5'-Diphosphate
|
|
|
RAB11FIP3 |
RAB11 family interacting protein 3 |
- VxPx cargo-targeting to cilium
|
|
|
|
RAB11FIP4 |
RAB11 family interacting protein 4 |
|
|
|